Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)
- 1 February 2004
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 93 (3) , 307-312
- https://doi.org/10.1016/j.amjcard.2003.10.009
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemiaThe American Journal of Cardiology, 2002
- Effect of very-low–dose niacin on high-density lipoprotein in patients undergoing long-term statin therapyAmerican Heart Journal, 2002
- American diabetes association position statement: evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complicationsJournal of the American Dietetic Association, 2002
- Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary DiseaseNew England Journal of Medicine, 2001
- Treatment of hyperlipidemia with combined niacin–statin regimensThe American Journal of Cardiology, 1998
- Effect of Low-Dose Niacin on High-Density Lipoprotein Cholesterol and Total Cholesterol/High-Density Lipoprotein Cholesterol RatioArchives of internal medicine (1960), 1988
- Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving LovastatinNew England Journal of Medicine, 1988
- Clofibrate and Niacin in Coronary Heart DiseaseJAMA, 1975
- Nicotinic Acid Treatment of HypercholesteremiaJAMA, 1961
- Hypercholesteremia and nicotinic acidThe American Journal of Medicine, 1961